Literature DB >> 24262129

One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?

Elisabeth Heffermehl Lange1, Ragnar Nesvåg2, Petter Andreas Ringen3, Cecilie Bhandari Hartberg4, Unn Kristin Haukvik5, Ole Andreas Andreassen3, Ingrid Melle3, Ingrid Agartz5.   

Abstract

Longitudinal studies on first-episode psychosis (FEP) patients have shown a decrease of substance use disorders (SUDs) over the first years of illness, but there has been less focus on the gender aspect. The present study examines stability of alcohol and illicit substance use, with specific focus on gender, in a one year follow-up investigation of 154 FEP patients (91 men, 63 women) in Oslo, Norway, using criteria for DSM-IV substance use disorder diagnosis, the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Use Disorders Identification Test (DUDIT). The results show that cannabis was the most frequently used illicit substance at both times. Significantly more men (34%) than women (13%) had a current illicit SUD at baseline. At follow-up, the rate of illicit SUDs was significantly reduced in men (18%) but not in women (11%). There were no significant gender differences in the rate of current alcohol use disorders (AUD) (men 14%; women 8%) at baseline, and no significant reduction in AUD in any of the genders at follow-up. At follow-up, total AUDIT and DUDIT scores were reduced in men only. In conclusion, the high and persistent rate of SUDs, particularly of cannabis, among men and women during the first year of treatment for psychosis should be addressed in the clinical management of the patients. Female FEP patients who are also substance users may be particularly vulnerable in this regard and warrant closer attention.
© 2014.

Entities:  

Mesh:

Year:  2013        PMID: 24262129     DOI: 10.1016/j.comppsych.2013.08.018

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  7 in total

1.  Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.

Authors:  Leslie Marino; Jennifer Scodes; Talia Richkin; Jean-Marie Alves-Bradford; Ilana Nossel; Melanie Wall; Lisa Dixon
Journal:  Schizophr Res       Date:  2020-05-28       Impact factor: 4.939

2.  A Retrospective Study of the Clinical Characteristics Associated with Alcohol and Cannabis use in Early Phase Psychosis.

Authors:  Jacob Cookey; Jacob McGavin; Candice E Crocker; Kara Matheson; Sherry H Stewart; Philip G Tibbo
Journal:  Can J Psychiatry       Date:  2020-02-04       Impact factor: 4.356

3.  Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.

Authors:  Esther Setién-Suero; Karl Neergaard; Mariluz Ramírez-Bonilla; Patricia Correa-Ghisays; Lourdes Fañanás; Benedicto Crespo-Facorro; Rosa Ayesa-Arriola
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

4.  Hazardous alcohol use in a sample of first episode psychosis patients in Singapore.

Authors:  Laxman Cetty; Shazana Shahwan; Pratika Satghare; Fiona Devi; Boon Yiang Chua; Swapna Verma; Helen Lee; Siow Ann Chong; Mythily Subramaniam
Journal:  BMC Psychiatry       Date:  2019-03-15       Impact factor: 3.630

5.  First-episode psychosis and substance use in Nelson Mandela Bay: Findings from an acute mental health unit.

Authors:  Yanga Thungana; Zukiswa Zingela; Stephan van Wyk
Journal:  S Afr J Psychiatr       Date:  2019-10-24       Impact factor: 1.550

6.  Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis.

Authors:  Priyanthi B Gjerde; Synne W Steen; Trude S J Vedal; Nils Eiel Steen; Elina J Reponen; Ole A Andreassen; Vidar M Steen; Ingrid Melle
Journal:  Front Psychiatry       Date:  2022-03-29       Impact factor: 4.157

Review 7.  Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review.

Authors:  Laura Prieto-Arenas; Ignacio Díaz; M Carmen Arenas
Journal:  Brain Sci       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.